Dr. Arash David Matian, DO

Dr. Matian practices at Prime Care Physicians in Sherman Oaks, California.

Dr. Matian's NPI, 1558300582, was assigned on June 5, 2006. Dr. Matian graduated from WesternU College of Osteopathic Medicine of the Pacific in 1999. Dr. Matian holds California license 20A7841.

Dr. Matian's primary practice is Prime Care Physicians, at 13425 Ventura Blvd, Sherman Oaks, CA 91423. The practice phone is (818) 995-7784.

Dr. Matian's primary practice is Prime Care Physicians in Sherman Oaks, California. The medical group on file is Prime Care Physicians. Dmand AI also links Dr. Matian to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Matian practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Matian's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Matian is board certified in family practice and osteopathic manipulative medicine by the AOA Board of Family Physicians. Dmand AI has Dr. Matian's licenses on file in 8 states: California, Georgia, Kentucky, North Carolina, New York, Ohio, Virginia and South Carolina.

Dmand AI lists aneurysm, chronic hypertension, enlarged prostate, fibromyalgia and chronic pain, gout, high cholesterol, insomnia and lower back pain among the conditions Dr. Matian treats.

CMS data shows 169 Medicare services from Dr. Matian across 2 procedure codes in 2024, all of them office visits, for 36 Medicare patients. Medicare paid $19,505 for them. Every service was in an office.

CMS counts 36 Medicare patients who saw Dr. Matian in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 50% are also on Medicaid. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Matian's median patient age at 50, with 54% women.

In 2024, Dr. Matian wrote 1,302 Medicare Part D claims for 131 patients. 91% of them were for generic drugs. CMS names the drug for 900 of them, across 38 drugs with 11 or more claims each, at $19,649 in total drug cost. In 2023, CMS named 997 claims across 44 drugs.

Dmand AI links 1 paper to Dr. Matian. Dr. Matian's most frequent co-authors are Anthony F. Jerant, MD and Richard G. Lasslo, MD.

Dmand AI links Dr. Matian to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Diabetes Mellitus, Type 2, Meningococcal Infections and Diabetes Mellitus. Open Payments lists research payments to Dr. Matian that name 1 trial.

CMS Open Payments shows 99 general payments to Dr. Matian from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Alnylam Pharmaceuticals Inc. paid the most, $1,310. It also lists 2 research payments totaling $6,954 from 2023 to 2024, naming 1 clinical trial.

Dr. Matian graduated from WesternU College of Osteopathic Medicine of the Pacific in 1999. Dr. Matian is a member of AOA.

Dr. Matian is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.